Biological Abnormalities Associated with Crohn’s Disease
- 1 Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco
- 2 Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco
- 3 Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco
- 4 Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco
- 5 Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco
- 6 Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco
- 7 Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco
- 8 Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco
- 9 Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco
- 10 Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco
- 11 Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco
- 12 Faculty of Medicine, Dentistry and Pharmacy, Sidi Mohammed Ben Abdellah University, Fez, Morocco
Abstract
Background: Crohn’s disease is a chronic inflammatory bowel disorder with complex and multifactorial pathogenesis and presentations. This retrospective study aims to analyze the biological abnormalities observed at the initial diagnosis of Crohn’s disease in a cohort of 231 patients. Methods: We performed a five-year retrospective study at the Hepato-Gastroenterology Department of University Hospital Hassan II in Fez, Morocco, involving 231 patients diagnosed with Crohn’s disease. A standardized form was used to extract data from medical charts and the Hosix electronic medical system. With an emphasis on hematologic, inflammatory, and nutritional parameters, as well as superinfections at presentation, demographic, clinical, and paraclinical variables were gathered. Results: The cohort’s mean age was 37.8 ± 12.2 years, and the majority of participants (66.7%) were female. Seventy-seven percent of patients had a chronic disease onset when they first arrived, and the average diagnostic delay was 16.7 months. 1) Inflammatory markers: Of the 196 patients tested, 91.8% had elevated fecal calprotectin (74.8% had >250 µg/g), and 83% had elevated C-reactive protein. 2) Anemia: Found in 61 percent of patients (n = 139), primarily microcytic hypochromic; 20 percent had iron deficiency, 44.6 percent had inflammation, and 35.4 percent had mixed. 3) Nutritional deficiencies were prevalent and included hypoalbuminemia (59%), vitamin D deficiency (90%), and hypocalcemia (39%), as well as hypomagnesemia (17%). 4) 24.8 percent of patients experienced superinfections, primarily from Entamoeba histolytica (14 percent) and Clostridium difficile (9.2 percent). Conclusion: These results highlight how Crohn’s disease affects more than just the gastrointestinal tract. To improve patient outcomes and optimize management strategies, routine evaluation of inflammatory markers, hematological parameters, and nutritional status are essential.
- Burisch, J., Zhao, M., Odes, S., De Cruz, P., Vermeire, S., Bernstein, C.N., et al . (2023) The Cost of Inflammatory Bowel Disease in High-Income Settings: A Lancet Gastroenterology & Hepatology Commission. The Lancet Gastroenterology & Hepatology , 8, 458-492. https://doi.org/10.1016/s2468-1253(23)00003-1
- Ng, S.C., Shi, H.Y., Hamidi, N., Underwood, F.E., Tang, W., Benchimol, E.I., et al . (2017) Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21st Century: A Systematic Review of Population-Based Studies. The Lancet , 390, 2769-2778. https://doi.org/10.1016/s0140-6736(17)32448-0
- Torres, J., Mehandru, S., Colombel, J. and Peyrin-Biroulet, L. (2017) Crohn’s Disease. The Lancet , 389, 1741-1755. https://doi.org/10.1016/s0140-6736(16)31711-1
- Ananthakrishnan, A.N., Adler, J., Chachu, K.A., Nguyen, N.H., Siddique, S.M., Weiss, J.M., et al . (2023) AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease. Gastroenterology , 165, 1367-1399. https://doi.org/10.1053/j.gastro.2023.09.029
- van Rheenen, P.F., Van de Vijver, E. and Fidler, V. (2010) Faecal Calprotectin for Screening of Patients with Suspected Inflammatory Bowel Disease: Diagnostic Meta-analysis. BMJ , 341, c3369. https://doi.org/10.1136/bmj.c3369
- Fraga, M. (2012) Fecal Calprotectin: Diagnostic Tool in Inflammatory Bowel Diseases. Revue Médicale Suisse , 8, 1669-1673.
- Fédération Française de Gastro-Entérologie (FMC-HGE) (2020) Initial Diagnosis, Follow-Up of IBD and Detection of Complications (ECCO-ESGAR 2019 Guidelines). FMC-Gastro.
- MICI Commission, Reflection Group of Hepato-Gastroenterology Cabinets and Groups (CREGG) (2014) IBD Memo: Assessment of Crohn’s Disease Activity.
- French Association for Continuing Medical Education in Hepato-Gastroenterology (2025) POSTU; 92-93.
- Gracie, D.J. and Williams, C. (2018) Prevalence of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Alimentary Pharmacology & Therapeutics , 47, 620-634.
- Cohen, R.D. (2018) Iron Deficiency and Anemia in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology , 16, 617-628.
- Khan, K.J. (2020) Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Gastroenterology , 158.
- Orthodiet. Ce qu’il faut savoir sur la maladie de Crohn et les carences nutrition-nelles. https://www.orthodiet.org/ce-quil-faut-savoir-sur-la-maladie-de-crohn-et-les-carences-nutritionnelles